HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Barry J Goldstein Selected Research

3- ((6- (ethylsulfonyl)- 3- pyridinyl)oxy)- 5- (2- hydroxy- 1- methylethoxy)- N- (1- methyl- 1H- pyrazol- 3- yl)benzamide

12/2011Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Barry J Goldstein Research Topics

Disease

39Type 2 Diabetes Mellitus (MODY)
09/2016 - 03/2002
14Hypoglycemia (Reactive Hypoglycemia)
09/2016 - 03/2003
9Insulin Resistance
08/2015 - 06/2002
8Body Weight (Weight, Body)
09/2016 - 09/2007
6Obesity
01/2015 - 12/2002
5Hyperglycemia
01/2007 - 09/2002
3Weight Gain
03/2015 - 01/2007
3Reperfusion Injury
02/2009 - 03/2007
2Albuminuria
01/2015 - 05/2008
2Constipation
01/2013 - 04/2010
2Diarrhea
01/2013 - 04/2010
2Myocardial Ischemia (Ischemic Heart Diseases)
02/2009 - 03/2007
2Inflammation (Inflammations)
01/2009 - 11/2003
2Vascular Diseases (Vascular Disease)
11/2008 - 02/2007
2Dyslipidemias (Dyslipidemia)
01/2007 - 12/2006
1Edema (Dropsy)
09/2016
1Renal Insufficiency (Renal Failure)
05/2013
1Weight Loss (Weight Reduction)
05/2013
1Chronic Renal Insufficiency
05/2013
1Cellulitis
04/2013
1Chronic Kidney Failure (Chronic Renal Failure)
04/2013
1Headache (Headaches)
04/2013
1Neoplasms (Cancer)
01/2013
1Pancreatitis
01/2013
1Kidney Diseases (Kidney Disease)
05/2008
1Herpes Zoster
05/2008
1Atherosclerosis
05/2008
1Diabetes Complications
05/2008
1Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2007
1Hypoadiponectinemia
06/2007
1Myocardial Infarction
03/2007
1Infarction (Infarctions)
03/2007
1Cardiovascular Diseases (Cardiovascular Disease)
02/2007
1Coronary Disease (Coronary Heart Disease)
11/2005
1Mitochondrial Diseases (Mitochondrial Disease)
04/2005
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2003

Drug/Important Bio-Agent (IBA)

18Sitagliptin Phosphate (Januvia)FDA Link
09/2016 - 08/2007
12Metformin (Glucophage)FDA LinkGeneric
09/2016 - 03/2003
11Glucose (Dextrose)FDA LinkGeneric
11/2015 - 09/2002
11AdiponectinIBA
01/2015 - 09/2002
10Insulin (Novolin)FDA Link
12/2011 - 09/2002
5Hypoglycemic Agents (Hypoglycemics)IBA
09/2016 - 01/2003
5Glipizide (Glucotrol)FDA LinkGeneric
05/2013 - 03/2003
5Rosiglitazone (Avandia)FDA Link
03/2013 - 03/2002
4Pioglitazone (Actos)FDA Link
09/2016 - 03/2002
4Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
03/2015 - 03/2003
4AdipokinesIBA
05/2008 - 09/2002
3Triglycerides (Triacylglycerol)IBA
08/2015 - 01/2007
3LipidsIBA
08/2015 - 12/2006
3AMP-Activated Protein KinasesIBA
02/2009 - 11/2008
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2009 - 09/2002
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2009 - 05/2005
3Pharmaceutical PreparationsIBA
05/2008 - 03/2002
3ThiazolidinedionesIBA
01/2007 - 03/2002
3Protein Tyrosine PhosphatasesIBA
05/2005 - 06/2002
2Dipeptidyl-Peptidase IV InhibitorsIBA
11/2015 - 03/2015
2AlbuminsIBA
01/2015 - 05/2008
2Hemoglobins (Hemoglobin)IBA
04/2013 - 03/2013
2Peroxynitrous Acid (Peroxynitrite)IBA
01/2009 - 03/2007
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2009 - 03/2007
2Transcription Factors (Transcription Factor)IBA
12/2007 - 01/2007
2Proteins (Proteins, Gene)FDA Link
03/2007 - 05/2005
2PPAR alphaIBA
01/2007 - 12/2006
2PPAR gammaIBA
01/2007 - 09/2002
2Biomarkers (Surrogate Marker)IBA
09/2006 - 11/2003
2Sulfhydryl Compounds (Thiols)IBA
05/2005 - 06/2003
12- (2,5- difluorophenyl)- 5- (2- (methylsulfonyl)- 2,6- dihydropyrrolo(3,4- c)pyrazol- 5(4H)- yl)tetrahydro- 2H- pyran- 3- amineIBA
11/2015
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
11/2015
1antineoplaston A10 (A 10)IBA
05/2013
13- ((6- (ethylsulfonyl)- 3- pyridinyl)oxy)- 5- (2- hydroxy- 1- methylethoxy)- N- (1- methyl- 1H- pyrazol- 3- yl)benzamideIBA
12/2011
1Insulin Glargine (Lantus)FDA Link
12/2011
1GlucokinaseIBA
12/2011
1AntioxidantsIBA
02/2009
1nucleotide pyrophosphataseIBA
02/2009
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
02/2009
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2009
1Oxidants (Oxidizing Agents)IBA
05/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2008
1Hormones (Hormone)IBA
05/2008
1NF-kappa B (NF-kB)IBA
12/2007
1NF-KappaB Inhibitor alphaIBA
12/2007
1I-kappa B KinaseIBA
12/2007
1Oxidoreductases (Dehydrogenase)IBA
03/2007
1NADP (NADPH)IBA
03/2007
1Superoxides (Superoxide)IBA
03/2007
1Nitric Oxide Synthase (NO Synthase)IBA
03/2007
1NADPH Oxidase 2IBA
03/2007
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2007
1HDL CholesterolIBA
01/2007
1Protein Isoforms (Isoforms)IBA
01/2007
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2007
1tesaglitazarIBA
12/2006
1CholesterolIBA
11/2005
1CytokinesIBA
04/2005
1Fatty Acids (Saturated Fatty Acids)IBA
04/2005
1Amyloid (Amyloid Fibrils)IBA
04/2005
1DNA (Deoxyribonucleic Acid)IBA
11/2003
1Dithiothreitol (Cleland's Reagent)IBA
06/2003

Therapy/Procedure

15Glycemic Control
09/2016 - 09/2002
13Therapeutics
09/2013 - 04/2005